Development Exclusivity Sample Clauses
The Development Exclusivity clause establishes that one party is granted exclusive rights to develop a specific product, technology, or project, preventing the other party from engaging in similar development activities with third parties. In practice, this means that during the exclusivity period, the party receiving exclusivity can pursue development without competition from the disclosing party or its affiliates, and the disclosing party is restricted from licensing or collaborating on similar developments with others. This clause is primarily used to protect the investment and competitive advantage of the party undertaking development, ensuring they have a unique opportunity in the market and reducing the risk of parallel competing projects.
POPULAR SAMPLE Copied 62 times
Development Exclusivity. For so long as a Joint Development Plan is in place, neither Party shall, except in connection with the Joint Development Activities, undertake any activities itself, or undertake any joint development activities in collaboration with or on behalf of any third party, in connection with the Joint Development Activity Field applicable to such Joint Development Plan. Notwithstanding the foregoing, ERS is expressly permitted to continue to engage in existing contractual arrangements, and to enter into new contractual arrangements, related to research, development, testing, and analysis regarding existing and future ERS materials, technologies, and products with parties that are not commercializing such materials, technologies and products, including third party consultants, laboratories, universities, research centers, research and development contractors, and other contractors; provided, however, that (a) ERS shall have the exclusive right under any such contractual arrangement to use and license any Intellectual Property developed under such contractual arrangement for commercial purposes in the Field, and (b) ERS has the right under any such contractual arrangement to oversee or control the disclosure and commercial use of such Intellectual Property in a manner that protects the Parties’ interests in such Intellectual Property that might have commercial applications in the Field. ERS shall, for so long as such a Joint Development Plan is in effect but subject to any confidentiality obligations ERS has to third parties, provide Stepan a monthly update on Products or Derivatives arising from its own development efforts, or those efforts resulting from such contractual arrangements, that are relevant to the Joint Development Activity Field(s) in effect at the time of such update.
Development Exclusivity. Each party agrees not to research or develop Licensed Products for use in the Field in the Territory during the term of this Agreement other than as provided for under this Agreement.
Development Exclusivity. During the Development Period, neither Party nor any of its Affiliates will, directly or indirectly by granting rights to a Third Party, develop, manufacture or commercialize any bispecific or multispecific antibody or antibody-like polypeptide, other than the Product, that contains [***] Binding Domain and [***] Binding Domain (“Competing Product”), alone or together with a Third Party.
Development Exclusivity. As between the Parties, subject to Section 2.1 and Section 2.2 and the other terms of this Agreement, Organon shall have the exclusive right, but not the obligation, to conduct all Development involving any Licensed Product after the Effective Date. Without limiting the foregoing, upon and after the Execution Date, except as provided in Sections 2.1 and 2.2, Daré shall not, and shall cause its Affiliates not to, without the advance, written consent or request of Organon, anywhere in the world: (a) conduct any Clinical Trials involving a Licensed Product, (b) seek, obtain or maintain any Marketing Authorization involving a Licensed Product, (c) generate any new Regulatory Materials involving a Licensed Product, (d) except to the extent required by Applicable Law and with notice to Organon, communicate with any Regulatory Authority regarding any Licensed Product, Daré Marketing Authorizations or Daré Regulatory Materials, or (e) assign, license, sublicense or otherwise grant or convey any rights under any of the Product Trademarks, Daré Know-How or Daré Patents for any Licensed Product for Exploitation in the Field.
Development Exclusivity. During the Development ----------------------- Exclusivity Term, neither Party shall (i) develop Products outside of this Agreement, nor (ii) enter into any agreement with any third party for the development of Products. In the event that Endo intends, at any time, to request Lavipharm to undertake the Non-Clinical Development of any Products in addition to the two Initial Products referred to in Section 2.03 hereinabove, Endo shall provide Lavipharm with written notice of such intention at least three (3) months prior to the expected commencement of such activities by Lavipharm.